Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-14-003904

Director acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BRADSHER NEAL C · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2014-06-30 Exercise or conversion : show line 1 in the form +20,000 $2.30 $46,000 62,908 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-06-30 Exercise or conversion : show line 2 in the form Option To Purchase Common Shares −20,000 $2.30 2014-07-01 20,000 0 D
Loading xslF345X03/p1488857.xml…